Investment Institute
Macroeconomic Research

China: Quantifying the impact of trade war

  • 16 August 2018 (7 min read)

Key points:

  • China’s rapid advancement in technology and innovation has created a structural conflict with the current leader, the US.
  • The trade dispute is merely a disguise of this structural conflict, making it much harder to resolve than those between traditional US allies, including the European Union, Canada and Mexico.
  • With the situation still fluid, we outline three scenarios of how the trade war may evolve and consider their impacts on the Chinese economy.
  • Our results show that the first-round impacts on China’s exports are manageable, worth 0.1%, 0.5% and 0.8% of GDP in each of the three scenarios.
  • The second-round impacts are more complex, uncertain and potentially more damaging. We estimate that the subsequent shocks to domestic investment and employment, disruptions to the global supply-chain and tighter financial conditions could amount to an additional 0.1%, 0.4% and 0.7% of GDP.
  • Against mounting downside risks, Beijing has started to adjust domestic policy to safeguard the economy. However, it has refrained from using renminbi (RMB) devaluation to fight the trade war, as this would run the risk of reigniting capital outflows and provoking more hostility from the US.

Trade war: What is the end-game?

The dramatic escalation of Sino-US trade tension has come as a major shock to global financial markets. From initial tariffs targeting solar panels, washing machines, steel and aluminium, to a more broad-based tax on $50bn of technology products1 , the Trump administration has significantly ramped up its protectionist measures against China over the past six months. With ongoing threats of more tariffs to come, fears of an all-out trade war have weighed on Chinese markets and clouded the economic outlook.

  • VGhlc2UgdGFyaWZmcyB3ZXJlIGltcGxlbWVudGVkIGFmdGVyIHRoZSBicmVha2Rvd24gb2YgYSBmZXcgcm91bmRzIG9mIFNpbm8tVVMgbmVnb3RpYXRpb24sIHdoZXJlIHRoZSBVUyByZWZ1c2VkIHRvIGFjY2VwdCBhIG51bWJlciBvZiBjb25jZXNzaW9ucyBCZWlqaW5nIG9mZmVyZWQgdG8gY2xvc2UgdGhlIHRyYWRlIGdhcCDigJMgaW5jbHVkaW5nIGJ1eWluZyBtb3JlIFVTIHByb2R1Y3RzLCBvcGVuaW5nIGl0cyBtYXJrZXQgYW5kIHN0cmVuZ3RoZW5pbmcgdGhlIHByb3RlY3Rpb24gb2YgaW50ZWxsZWN0dWFsIHByb3BlcnR5Lg==

Have our latest insights delivered straight to your inbox

Subscribe to updates.

Related Articles

Macroeconomic Research

India’s economy: A compelling growth and investment story but challenges remain

  • by Danny Richards
  • 11 June 2024 (10 min read)
Macroeconomic Research

Eurozone corporate profits outlook: How they could influence the ECB

Macroeconomic Research

Will the US presidential election endanger an investment boom?


    This document is for informational purposes only and does not constitute investment research or financial analysis relating to transactions in financial instruments as per MIF Directive (2014/65/EU), nor does it constitute on the part of AXA Investment Managers or its affiliated companies an offer to buy or sell any investments, products or services, and should not be considered as solicitation or investment, legal or tax advice, a recommendation for an investment strategy or a personalized recommendation to buy or sell securities. 

    It has been established on the basis of data, projections, forecasts, anticipations and hypothesis which are subjective. Its analysis and conclusions are the expression of an opinion, based on available data at a specific date. 
    All information in this document is established on data made public by official providers of economic and market statistics. AXA Investment Managers disclaims any and all liability relating to a decision based on or for reliance on this document. All exhibits included in this document, unless stated otherwise, are as of the publication date of this document. 
    Furthermore, due to the subjective nature of these opinions and analysis, these data, projections, forecasts, anticipations, hypothesis, etc. are not necessary used or followed by AXA IM’s portfolio management teams or its affiliates, who may act based on their own opinions. Any reproduction of this information, in whole or in part is, unless otherwise authorised by AXA IM, prohibited. 

    Back to top